| __timestamp | Pharming Group N.V. | Protagonist Therapeutics, Inc. |
|---|---|---|
| Wednesday, January 1, 2014 | 14182353 | 7459000 |
| Thursday, January 1, 2015 | 15503028 | 11831000 |
| Friday, January 1, 2016 | 16183585 | 25705000 |
| Sunday, January 1, 2017 | 22382849 | 46181000 |
| Monday, January 1, 2018 | 33038206 | 59497000 |
| Tuesday, January 1, 2019 | 31777040 | 65003000 |
| Wednesday, January 1, 2020 | 41464134 | 74506000 |
| Friday, January 1, 2021 | 67178053 | 126006000 |
| Saturday, January 1, 2022 | 52531000 | 126215000 |
| Sunday, January 1, 2023 | 68914000 | 120161000 |
Unleashing insights
In the competitive world of biotechnology, innovation is the lifeblood of success. Over the past decade, Pharming Group N.V. and Protagonist Therapeutics, Inc. have been at the forefront of this race, each investing heavily in research and development (R&D) to drive breakthroughs. From 2014 to 2023, Protagonist Therapeutics consistently outpaced Pharming Group in R&D spending, with an average annual investment nearly 80% higher. Notably, in 2021, Protagonist's R&D expenses peaked at over 126 million, marking a 70% increase from 2017. Meanwhile, Pharming Group's R&D spending grew steadily, reaching its highest in 2023 with a 385% increase from 2014. This commitment to innovation underscores the strategic priorities of these companies as they strive to lead in the biotech sector. As investors and stakeholders look to the future, these trends highlight the critical role of R&D in shaping the next wave of medical advancements.
AbbVie Inc. or Protagonist Therapeutics, Inc.: Who Invests More in Innovation?
BeiGene, Ltd. vs Pharming Group N.V.: Strategic Focus on R&D Spending
United Therapeutics Corporation vs Protagonist Therapeutics, Inc.: Strategic Focus on R&D Spending
Comparing Innovation Spending: Intra-Cellular Therapies, Inc. and Protagonist Therapeutics, Inc.
Research and Development: Comparing Key Metrics for Insmed Incorporated and Protagonist Therapeutics, Inc.
Who Prioritizes Innovation? R&D Spending Compared for BioMarin Pharmaceutical Inc. and Protagonist Therapeutics, Inc.
Research and Development: Comparing Key Metrics for Halozyme Therapeutics, Inc. and Pharming Group N.V.
Pharming Group N.V. vs ADMA Biologics, Inc.: Strategic Focus on R&D Spending
Analyzing R&D Budgets: Pharming Group N.V. vs Amneal Pharmaceuticals, Inc.
Who Prioritizes Innovation? R&D Spending Compared for Pharming Group N.V. and Ligand Pharmaceuticals Incorporated
Research and Development: Comparing Key Metrics for Alkermes plc and Protagonist Therapeutics, Inc.
R&D Insights: How Protagonist Therapeutics, Inc. and Ligand Pharmaceuticals Incorporated Allocate Funds